SymBiosis Capital Partners, LLC
BENTONVILLE, AR · Quarter end: Mar 31, 2026 · Filed with SEC: May 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$52.8M2026 Q1
Positions6
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
The most recent 13F EDGAR holds under this CIK is 2026 Q1, filed 2026-05-12. Nothing has been filed since — the fund stopped filing, or it files under a different entity now. The positions below are a snapshot of that date, not a current portfolio.
SymBiosis Capital Partners, LLC reported 6 positions worth $52.8M as of March 31, 2026 (13F filed May 12, 2026). Largest holding: EVMN (55.8%). Biggest move: exit VSTM ($15.4M).
6 positions shown
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does SymBiosis Capital Partners, LLC hold as of Q1 2026?
SymBiosis Capital Partners, LLC reported 6 positions worth $52.8M in its Q1 2026 13F filing. Largest positions: EVMN (55.8%), IVA (24.8%), 96663EUR (10.3%), RANI (5.1%) and CLNN (4.0%).
What did SymBiosis Capital Partners, LLC buy in Q1 2026?
New positions: 96663EUR.
What did SymBiosis Capital Partners, LLC sell in Q1 2026?
Reduced: RANI, CLNN and IVA. Sold out entirely: VSTM, AMPG, PGEN, NUVB and AARD (6 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.